INVIVYD INC. - COMMON
0.9213
07-十月-24 15:59:55
15 分钟延时
股票
-0.0292
-3.07%
今日范围
0.9101 - 0.9700
ISIN
N/A
来源
NASDAQ
-
13 10月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Invivyd to Present Multiple Posters Highlighting Clinical Data from Adintrevimab During ID Week 2022
12 10月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics Announces Corporate Name Change to Invivyd
12 9月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics to Participate in Upcoming Investor Conferences
06 9月 2022 16:01:00 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
15 8月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Adagio Announces David Hering Named Permanent Chief Executive Officer and Director
05 7月 2022 07:25:58 条件 Nasdaq GlobeNewswire
-
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
01 7月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics Reports First Quarter 2022 Financial Results
13 5月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics Provides Update on Timing of Adintrevimab EUA Request
14 4月 2022 07:45:00 条件 Nasdaq GlobeNewswire
-
30 3月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics, Inc. Announces 2022 Annual Meeting of Stockholders
18 3月 2022 18:33:15 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics Announces David Hering Appointed Interim Chief Executive Officer
23 2月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics Announces ADG20 Development Plans and Pipeline Updates
22 2月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics Announces CEO Succession Plan
18 2月 2022 19:33:28 条件 Nasdaq GlobeNewswire
-
12 1月 2022 16:56:55 条件 Nasdaq GlobeNewswire
-
Adagio Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
06 1月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
14 12月 2021 07:00:00 条件 Nasdaq GlobeNewswire
-
29 11月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
22 11月 2021 06:30:00 条件 Nasdaq GlobeNewswire